CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells

Ritsu Suzuki, Hiroshi Sakamoto, Hideo Yasukawa, Masaaki Masuhara, Toru Wakioka, Atsuo Sasaki, Kentaro Yuge, Setsuro Komiya, Akio Inoue, Akihiko Yoshimura

研究成果: Article

74 引用 (Scopus)

抜粋

We have reported JAK-signaling modulators, CIS1 (cytokine-inducible SH2 protein-1), CIS3 and JAB (JAK2 binding protein), which are structurally related. In M1 myeloid leukemia cells, CIS3 was induced by neither interleukin 6 (IL6) nor interferon γ (IFNγ), while JAB was induced strongly by IFNγ and slightly by IL6 and leukemia inhibitory factor (ILF). Forced expression of CIS3 and JAB in M1 cells prevented IL6- or LIF-induced growth arrest and differentiation, even when their expression levels were comparable to endogenous ones in several cell lines such as HEL, UT-7, UFNγ-treated M1, and CTLL2 cells. Pretreatment of parental M1 cells with IFNγ but not IFNβ resulted in suppression of LIF-induced STAT3 activation and differentiation, further supporting that physiological level of JAB is sufficient to inhibit LIF-signaling. However, unlike JAB, CIS3 did not inhibit IFNγ-induced growth arrest, suggesting a difference in cytokine specificity between CIS3 and JAB. CIS3 inhibited STAT3 activation with slower kinetics than JAB and allowed rapid c-fos induction and partial FcγRI expression in response to IL6. In 293 cells, CIS3 as well as JAB bound to JAK2 tyrosine kinase domain (JH1), and inhibited its kinase activity, however, the effect of CIS3 on tyrosine kinase activity was weaker than that of JAB, indicating that CIS3 possesses lower affinity to JAK kinases than JAB. These findings suggest that CIS3 is a weaker inhibitor than JAB against JAK signaling, and JAB and CIS3 possess different regulatory roles in cytokine signaling.

元の言語English
ページ(範囲)2271-2278
ページ数8
ジャーナルOncogene
17
発行部数17
DOI
出版物ステータスPublished - 1998 10 29

    フィンガープリント

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

これを引用

Suzuki, R., Sakamoto, H., Yasukawa, H., Masuhara, M., Wakioka, T., Sasaki, A., Yuge, K., Komiya, S., Inoue, A., & Yoshimura, A. (1998). CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells. Oncogene, 17(17), 2271-2278. https://doi.org/10.1038/sj.onc.1202143